Literature DB >> 20065852

The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma.

Aashiyana F Koreishi1, Adam J Saenz, Dan O Persky, Hayan Cui, Allison Moskowitz, Craig H Moskowitz, Julie Teruya-Feldstein.   

Abstract

Recent data suggests the presence of cytotoxic (TIA-1 and granzyme B+) and regulatory T-cells (FOXP3+) in classical Hodgkin lymphoma (cHL) tissues has been shown to correlate with poor overall survival in mainly diagnostic biopsies. By tissue microarray analyses, we extend this observation to a cohort of relapsed/refractory cHL tissue biopsies and analyze immunohistochemical expression of FOXP3, TIA-1, and granzyme B in the inflammatory background and the tumor microenvironment. High expression of TIA-1 (>50%) correlated with poor overall survival (P<0.0001), low expression of FOXP3 (<25%) correlated with poor overall survival (P<0.01), and combined high TIA-1 (>50%) and low FOXP3 (<25%) correlated with poor overall survival (P<0.0001). Expression of cytotoxic and regulatory T-cells shows prognostic significance in the relapsed/refractory clinical setting of cHL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065852      PMCID: PMC3260943          DOI: 10.1097/PAI.0b013e3181c7138b

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  29 in total

1.  TiA1 in advanced-stage classical Hodgkin's lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells.

Authors:  Sophie Camilleri-Broët; Christophe Fermé; Françoise Berger; Eric Lepage; Serge Bain; Josette Brière; Béatrice Marmey; Philippe Gaulard; Josée Audouin
Journal:  Virchows Arch       Date:  2004-06-19       Impact factor: 4.064

2.  Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

Authors:  Craig H Moskowitz; Tarun Kewalramani; Stephen D Nimer; Maria Gonzalez; Andrew D Zelenetz; Joachim Yahalom
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

3.  Revisiting the prognostic value of regulatory T cells in patients with cancer.

Authors:  Cecile Badoual; Stephane Hans; Wolf H Fridman; Daniel Brasnu; Susan Erdman; Eric Tartour
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 4.  Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.

Authors:  S Poppema; A van den Berg
Journal:  Semin Cancer Biol       Date:  2000-10       Impact factor: 15.707

5.  Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.

Authors:  C V Hedvat; E S Jaffe; J Qin; D A Filippa; C Cordon-Cardo; G Tosato; S D Nimer; J Teruya-Feldstein
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

6.  Activated cytotoxic T cells as prognostic marker in Hodgkin's disease.

Authors:  J J Oudejans; N M Jiwa; J A Kummer; G J Ossenkoppele; P van Heerde; J W Baars; P M Kluin; J C Kluin-Nelemans; P J van Diest; J M Middeldorp; C J Meijer
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

7.  Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.

Authors:  Takashi Ishida; Toshihiko Ishii; Atsushi Inagaki; Hiroki Yano; Hirokazu Komatsu; Shinsuke Iida; Hiroshi Inagaki; Ryuzo Ueda
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

8.  Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.

Authors:  Tomás Alvaro; Marylène Lejeune; Ma Teresa Salvadó; Ramón Bosch; Juan F García; Joaquín Jaén; Alison H Banham; Giovanna Roncador; Carlos Montalbán; Miguel A Piris
Journal:  Clin Cancer Res       Date:  2005-02-15       Impact factor: 12.531

9.  Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.

Authors:  Cyrus V Hedvat; Abhijith Hegde; Raju S k Chaganti; Beiyun Chen; Jing Qin; Daniel A Filippa; Stephen D Nimer; Julie Teruya-Feldstein
Journal:  Hum Pathol       Date:  2002-10       Impact factor: 3.466

10.  Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Authors:  Juan F García; Francisca I Camacho; Manuel Morente; Máximo Fraga; Carlos Montalbán; Tomás Alvaro; Carmen Bellas; Angel Castaño; Ana Díez; Teresa Flores; Carmen Martin; Miguel A Martinez; Francisco Mazorra; Javier Menárguez; Maria J Mestre; Manuela Mollejo; Ana I Sáez; Lydia Sánchez; Miguel A Piris
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

View more
  13 in total

Review 1.  Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.

Authors:  Rajendra Gharbaran
Journal:  Tumour Biol       Date:  2016-06-18

Review 2.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Authors:  Camilla A Lindqvist; Lisa H Christiansson; Ingrid Thörn; Sara Mangsbo; Gabriella Paul-Wetterberg; Christer Sundström; Thomas H Tötterman; Bengt Simonsson; Gunilla Enblad; Per Frisk; Ulla Olsson-Strömberg; Angelica S I Loskog
Journal:  Immunology       Date:  2011-04-05       Impact factor: 7.397

4.  T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2010-10-12

5.  Express: A database of transcriptome profiles encompassing known and novel transcripts across multiple development stages in eye tissues.

Authors:  Gungor Budak; Soma Dash; Rajneesh Srivastava; Salil A Lachke; Sarath Chandra Janga
Journal:  Exp Eye Res       Date:  2018-01-11       Impact factor: 3.467

6.  Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.

Authors:  Dammy Pinheiro; Yu-Mei Chang; Hannah Bryant; Balazs Szladovits; Tim Dalessandri; Lucy J Davison; Elizabeth Yallop; Emily Mills; Chiara Leo; Ana Lara; Anneliese Stell; Gerry Polton; Oliver A Garden
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

Review 7.  Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

Authors:  Giovanni D'Arena; Candida Vitale; Marta Coscia; Agostino Festa; Nicola Matteo Dario Di Minno; Vincenzo De Feo; Michele Caraglia; Gioacchino Calapai; Luca Laurenti; Pellegrino Musto; Giovanni Di Minno; Daniela Fenoglio
Journal:  J Immunol Res       Date:  2017-12-21       Impact factor: 4.818

8.  Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma.

Authors:  Matias Autio; Suvi-Katri Leivonen; Oscar Brück; Satu Mustjoki; Judit Mészáros Jørgensen; Marja-Liisa Karjalainen-Lindsberg; Klaus Beiske; Harald Holte; Teijo Pellinen; Sirpa Leppä
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

9.  A Multi-Component Model of Hodgkin's Lymphoma.

Authors:  Martin S Staege
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

Review 10.  Tumor Microenvironment.

Authors:  Borros Arneth
Journal:  Medicina (Kaunas)       Date:  2019-12-30       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.